(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.

(The Center Square) – Gov. Gavin Newsom announced Thursday he is rolling out an effort to lower the price of insulin to $11. CalRx, the state-run program that aims to lower the cost of insulin and ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

The new CalRx insulin will work as a generic version of glargine and could save patients $2,000 to $4,000 per year ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...

A new cheaper biosimilar version of Sanofi's Lantus (insulin glargine) has been launched in the UK today, and is likely to dent sales of the blockbuster product. Lilly and Boehringer Ingelheim's (BI) ...